Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

NOT YET RECRUITING

NCT07224867

The Effects of Liquid IV's Multi-Ingredient Recovery Supplement on Muscle Recovery Following Exercise

Sponsor: Applied Science & Performance Institute

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the efficacy of a multi-ingredient recovery supplement . The research will focus on strength recovery and performance maintenance assessing reductions in soreness and inflammation, as well as muscle repair and damage mitigation. By investigating these key recovery metrics, this study aims to investigate the efficacy of this supplement as a solution for active individuals seeking to optimize post-exercise recovery.

Official title: The Effects of Liquid IV's Multi-Ingredient Recovery Supplement, on Muscle Recovery Following Exercise: A Randomized Crossover Study

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

Start Date

2026-05-01

Completion Date

2026-10-01

Last Updated

2026-04-09

Healthy Volunteers

Yes

Conditions

Muscle Damage Strength Recovery Perceived Recovery Perceived Muscle Soreness Physical Performance Muscle Recovery

Interventions

DIETARY_SUPPLEMENT

proprietary post workout recovery supplement

DIETARY_SUPPLEMENT

Control placebo

inactive/inert placebo mix

Inclusion Criteria: * Healthy males or females aged 18-55 years old. * Must be recreationally trained or trained/developmental as previously defined (McKay et al., 2021). * Able to read and write in English. * Cessation of current use of tart cherry extract, protein powders, essential amino acids/BCAAs, calcium fructoborate, boron, or anabolic agents for a minimum of 1 week prior to, and throughout the duration of the study. * Willing to maintain regular supplement routine otherwise during the trial, and will not introduce or discontinue a supplement, other than what was previously mentioned. * Will not participate in any strenuous exercise for a minimum of 1-week prior to exercise performance assessments, as well as during the days of exercise testing. Strenuous exercise as defined for this study includes ½ and full marathons (or more), heavy (i.e.,\>80% 1RM) lifting, and any high intensity, physical activity that could make your muscles sore. * During the study, you agree not to take any NSAIDs or other anti-inflammatory medications. Exclusion Criteria: * Sedentary * Highly trained/national level or professional athlete * Known diagnosis of any cardiovascular, metabolic, musculoskeletal, endocrine, or renal disease/disorder. * Recent musculoskeletal injury (\<3-months) * Recent orthopedic surgery (\<12-months) * History or current malignancy. * Current respiratory infection (i.e., cold) or high temperature (fever) within the past 4-weeks. * Previous gastrointestinal surgery within the past 12 months. * Regular smoker. * Regular drinker (\>14 drinks per week). * Those regularly using anti-inflammatory drugs within the last 4-weeks. * Current use of prescription medications that may influence adaptation to exercise (hormone therapies, peptides, etc.). * Allergies to study-related materials. * Any condition that impairs their ability to complete the required exercises. * Female subjects must not be pregnant or lactating. * Are unable to provide informed consent or are non-English speakers. * Presently using GLP-1 medications.

Locations (1)

Applied Science & Performance Institute

Tampa, Florida, United States